Wang Jun-Ke, Wu Zhen-Ru, Su Fei, Ma Wen-Jie, Hu Hai-Jie, Li Fu-Yu
Department of Biliary Surgery, West China Hospital, Sichuan University, Chengdu 610041, Chengdu China.
Laboratory of Pathology, West China Hospital, Sichuan University, Chengdu 610041, Chengdu China.
Open Med (Wars). 2018 Dec 31;13:456-459. doi: 10.1515/med-2018-0069. eCollection 2018.
Hepatic epithelioid hemangioendothelioma (HEHE) is an extremely rare malignancy of vascular origin. When most patients with HEHE are diagnosed, they have a diffuse nodular phenotype, which is usually unresectable. A single nodular phenotype is found in only a small proportion (13%) of patients, and most are reported to be located in the right lobe of the liver. Although the prognosis of HEHE is considered more favorable than that of other hepatic malignant tumors, the 5-year survival rate is reported to be 64% after treatment. Herein, we present an unusual case of resectable HEHE of a single nodular type in the left lobe of the liver. The patient survived 15 years without recurrence after the multimodal treatment of radical resection and postoperative chemotherapy with thalidomide. The aim of the present study is to emphasize that multimodal treatment of radical resection followed by chemotherapy with thalidomide may achieve a relatively good survival outcome in patients with resectable HEHE of a single nodular type.
肝上皮样血管内皮瘤(HEHE)是一种极为罕见的血管源性恶性肿瘤。大多数HEHE患者确诊时具有弥漫性结节表型,通常无法切除。仅一小部分(13%)患者表现为单个结节表型,且多数报道位于肝右叶。尽管HEHE的预后被认为比其他肝脏恶性肿瘤更乐观,但据报道治疗后的5年生存率为64%。在此,我们报告一例罕见的可切除的肝左叶单结节型HEHE病例。该患者在接受根治性切除及沙利度胺术后化疗的多模式治疗后存活15年无复发。本研究的目的是强调对于可切除的单结节型HEHE患者,根治性切除后联合沙利度胺化疗的多模式治疗可能取得相对良好的生存结果。